The pooled prevalence of MTHFR TT in patients with any VOC was 2.4%, non-significantly higher than patients in steady state whereas the pooled prevalence of MTHFR TT was lower in patients with avascular necrosis than in patients without. The gene discussed is MTHFR; the disease is avascular necrosis.